14 completed, 3 unknown, 2 terminated, 1 active not recruiting. 9 Phase 2, 5 Phase 1, 3 Phase 3, 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 7, Recruiting 1, Unknown 1 |
| Phase 1 | 5 | Completed 3, Terminated 2 |
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Antimony Sodium Gluconate: new trials by email Literature Review of Antimony Sodium Gluconate trials Research Report on Antimony Sodium Gluconate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) Sodium Stibogluconate (SSG), Miltefosine, Miltefosine + Paromomycin - Cutaneous Leihmaniasis | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 900 | 2027-01-01 | 2026-03-10 |
| Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue Blood Flow Restriction + Small-Sided Games (BFR-SSG), Small-Sided Games (SSG) Control - Athletic Performance | Not applicable | Completed | Beijing Sport University | 40 | 2026-01-20 | 2026-03-27 |
| Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate Ciprofloxacin (BAYO9867), sodium stibogluconate (Pentostam) - Cutaneous Leishmaniasis | Phase 2 | Recruiting | Al-Mustafa University College | 80 | 2025-02-07 | 2025-09-30 |
| LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study LXE408, sodium stibogluconate, Paromomycin - Primary Visceral Leishmaniasis | Phase 2 | Completed | Drugs for Neglected Diseases | 52 | 2024-03-29 | 2025-12-18 |
| A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis Sodium stibogluconate / paramomycin - Visceral Leishmaniasis | Active not recruiting | University of York | 216 | 2022-05-22 | 2025-07-24 | |
| Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy Standard Sleeve Gastrectomy plus Anterior Crural Repair, Standard sleeve gastrectomy (SSG, the control group) - Obesity, Gastro Esophageal Reflux Disease | Not applicable | Unknown | Chinese University of Hong Kong | 50 | 2021-05-01 | 2021-05-12 |
| Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia Sodium Stibogluconate with allopurinol - Cutaneous Leishmaniasis | Completed | Institute of Tropical Medicine, Belgium | 105 | 2021-02-15 | 2024-03-18 | |
| Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations Sodium stibogluconate - Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2 | Unknown | First Affiliated Hospital of Jinan University | 5 | 2020-06-01 | 2021-06-09 |
| Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa Miltefosine, Paromomycin, Sodium stibogluconate - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 439 | 2018-01-24 | 2024-02-29 |
| Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients Pentostam - Cutaneous Leishmaniasis | Unknown | Sheba Medical Center | 100 | 2014-11-01 | 2014-11-03 | |
| Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa Liposomal amphotericin B (AmBisome®) and sodium stibogluconate, Liposomal amphotericin B + miltefosine, Miltefosine - Primary Visceral Leishmaniasis | Phase 2 | Completed | Drugs for Neglected Diseases | 151 | 2010-03-01 | 2017-04-24 |
| Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients Electro-thermo-coagulation, Sodium Stibogluconate, DAC N-055 - Wound Healing | Phase 2 | Completed | Waisenmedizin e. V. Promoting Access to Essential Medicine | 63 | 2010-01-01 | 2011-03-28 |
| A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis LEISH-F2 + MPL-SE, Sodium stibogluconate - Cutaneous Leishmaniasis | Phase 2 | Completed | Access to Advanced Health Institute (AAHI) | 45 | 2009-10-01 | 2013-12-11 |
| Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India RFH therapy, Sodium stibogluconate - Cutaneous Leishmaniasis | Phase 4 | Completed | Sarder Patel Medical College | 100 | 2009-08-01 | 2012-09-03 |
| Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome sodium stibogluconate - Myelodysplastic Syndromes | Phase 1 | Terminated | Northwestern University | 1 | 2009-07-01 | 2013-11-08 |
| Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers recombinant interferon alfa-2b, cisplatin, sodium stibogluconate - Stage IV Melanoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 22 | 2007-05-01 | 2020-07-24 |
| Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies Sodium Stibogluconate, Interferon Alpha-2b - Advanced Cancer, Solid Tumors | Phase 1 | Completed | M.D. Anderson Cancer Center | 33 | 2006-09-13 | 2018-11-15 |
| Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma recombinant interferon alfa-2b, sodium stibogluconate, SSG & interferon - Cancer | Phase 1 | Terminated | The Cleveland Clinic | 18 | 2005-10-01 | 2018-01-26 |
| Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis Sodium Stibogluconate, Paromomycin sulphate, SSG and Paromomycin sulphate - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 1142 | 2004-11-01 | 2016-03-22 |
| Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Sodium Stibogluconate (SSG) - Leishmaniasis | Phase 1 / Phase 2 | Completed | U.S. Army Medical Research and Development Command | 77 | 2004-10-01 | 2020-01-02 |
Showing 20 of 23. Sign in to see all of them.
Leishmaniasis, Cutaneous (8) · Leishmaniasis, Visceral (4) · Leishmaniasis (3) · Melanoma (3) · Myelodysplastic Syndromes (2) · Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma, Renal Cell (1) · Ependymoma (1) · Fatigue (1) · Gastroesophageal Reflux (1) · Glioblastoma (1) · Glioma (1) · Glioma, Subependymal (1) · Gliosarcoma (1)
Drugs for Neglected Diseases (4) · U.S. Army Medical Research and Development Command (3) · Institute of Tropical Medicine, Belgium (2) · Access to Advanced Health Institute (AAHI) (1) · Al-Mustafa University College (1) · Beijing Sport University (1) · Case Comprehensive Cancer Center (1) · Chinese University of Hong Kong (1) · First Affiliated Hospital of Jinan University (1) · M.D. Anderson Cancer Center (1) · Northwestern University (1) · Sarder Patel Medical College (1) · Sheba Medical Center (1) · The Cleveland Clinic (1) · University of California, San Francisco (1)
United States (8) · Ethiopia (5) · Kenya (4) · China (3) · Sudan (3) · Uganda (2) · Afghanistan (1) · India (1) · Iraq (1) · Israel (1) · Peru (1)
Ernest C. Borden, MD (2) · Ahmed M Musa, MD, Prof (1) · Aung Naing, MD (1) · Brian Schwartz, MD (1) · Eli Schwartz, M.D, DTMH (1) · Elizabeth Eklund, MD (1) · Franco Piazza, MD, MPH (1) · Glenn Wortmann, MD (1) · Jane Mbui, MD (1) · Johan Van Griensven (1) · Joseph Olobo, MD, Prof (1) · Kanade Shinkai, MD (1) · Manica Balasegaram (1) · Mezgebu Silamsaw, Dr (1)
PMID 20231896, PMID 21049063, PMID 21718522, PMID 22724029, PMID 25420793, PMID 26573827, PMID 27627654, PMID 35417717, PMID 36164254, PMID 37624352
P30CA043703 (1)